These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 19194557

  • 1. The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy.
    Chin HJ, Cho HJ, Lee TW, Na KY, Oh KH, Joo KW, Yoon HJ, Kim YS, Ahn C, Han JS, Kim S, Jeon ES, Jin DC, Kim YL, Park SH, Kim CD, Song YR, Kim SG, Kim YG, Lee JE, Oh YK, Lim CS, Lee SK, Chae DW, Cho WY, Kim HK, Jo SK, Progressive REnal disease and Medical Informatics and gEnomics Research (PREMIER) members.
    J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S22-9. PubMed ID: 19194557
    [Abstract] [Full Text] [Related]

  • 2. Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy.
    Tanaka S, Ninomiya T, Masutani K, Nagata M, Tsuchimoto A, Tsuruya K, Kitazono T.
    Clin Exp Nephrol; 2015 Dec; 19(6):1062-70. PubMed ID: 25700934
    [Abstract] [Full Text] [Related]

  • 3. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L, Cai K, Wang K, Luo Q.
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up.
    Cheng GY, Liu DW, Zhang N, Tang L, Zhao ZZ, Liu ZS.
    Clin Nephrol; 2013 Jul; 80(1):40-6. PubMed ID: 23391320
    [Abstract] [Full Text] [Related]

  • 7. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
    Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.
    Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Jun; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
    Zhu B, Yu DR, Lv JC, Lin Y, Li Q, Yin JZ, Du YY, Tang XL, Mao LC, Li QF, Sun Y, Liu L, Li XF, Fei D, Wei XY, Zhu CF, Cheng XX, Chen HY, Wang YJ.
    Am J Nephrol; 2018 Jun; 48(2):127-136. PubMed ID: 30110674
    [Abstract] [Full Text] [Related]

  • 12. Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy.
    Russo E, Drovandi S, Salvidio G, Verzola D, Esposito P, Garibotto G, Viazzi F.
    Nutr Metab Cardiovasc Dis; 2020 Nov 27; 30(12):2343-2350. PubMed ID: 32912790
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group.
    Donadio JV, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC.
    J Am Soc Nephrol; 1999 Aug 27; 10(8):1772-7. PubMed ID: 10446945
    [Abstract] [Full Text] [Related]

  • 16. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD.
    J Am Soc Nephrol; 2006 May 27; 17(5):1444-52. PubMed ID: 16611715
    [Abstract] [Full Text] [Related]

  • 17. Long-Term Outcomes in IgA Nephropathy.
    Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, Steenkamp R, Wong K, Turner AN, Wang K, Gale DP, Barratt J.
    Clin J Am Soc Nephrol; 2023 Jun 01; 18(6):727-738. PubMed ID: 37055195
    [Abstract] [Full Text] [Related]

  • 18. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O, Watier L, Rossert J, Stengel B, GN-Progress Study Group.
    QJM; 2008 Mar 01; 101(3):215-24. PubMed ID: 18245806
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
    Wakai K, Kawamura T, Endoh M, Kojima M, Tomino Y, Tamakoshi A, Ohno Y, Inaba Y, Sakai H.
    Nephrol Dial Transplant; 2006 Oct 01; 21(10):2800-8. PubMed ID: 16822793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.